An Investigational Drug for the Prevention of Chemotherapy-Induced Nausea and Vomiting (MK-0869-071)
Status:
Completed
Trial end date:
2004-02-11
Target enrollment:
Participant gender:
Summary
This protocol will study an investigational drug treatment plan against standard therapy in
the prevention of chemotherapy-induced nausea and vomiting in patients diagnosed with breast
cancer who are to be treated with up to 4 cycles of non-cisplatin moderately emetogenic
chemotherapy.